FDA approves first biosimilar for the treatment of cancer

By Newsroom America Feeds at 14 Sep 2017

The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer.

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm576112.htm

Categories:
Tags:

[D] [Digg] [FB] [R] [SU] [Tweet] [G]

NEWSMAIL